# Codex Review: medical_monitoring_timeline_data_coverage_20260802

Date: 2026-08-02 11:17 CST
Route: Codex direct (`codex-main`, high); no delegated agent, Hermes dispatch, or external route.

## Verdict

**PASS for this offline frontend contract slice; not a runtime or release approval.**

## Boundary Check

- Only monitor feature source/tests, the focused frontend contract test, and task evidence records were changed.
- No `frontend/src/App.jsx`, `frontend/src/styles.css`, backend/API/source registry/SQLite/runtime/provider, B6/C13 gate, or medical-writing surface was modified.
- 8911 and 5174 had no listeners; unrelated PID 43191/18911 was not touched.

## Codex Verification

- `node frontend/src/features/medical-monitoring/medicalMonitoringSubjectModels.test.mjs` passed.
- All 22 `frontend/src/features/medical-monitoring/*.test.mjs` files passed.
- `PYTHONPATH=. pytest -q tests/test_frontend_timeline_contract.py tests/test_frontend_unified_risk_workbench_contract.py tests/test_frontend_safety_projection_contract.py` passed: **41 passed**.
- `npm run build` passed: Vite **1925 modules transformed**; existing chunk-size warning only.
- Protected hashes unchanged: `App.jsx` `3346d9457805eb69bbeb8897fc9112ae809feecc1e45a6d7c50ce3b9190c9f61`; `styles.css` `f7020f5803e0c4a560a5614b525daff1a056f0201cc4f342f4e11fc1b3805479`.
- B6 review gate remained `pending_review`, 5 candidates/0 outcomes, `write_permitted=false`; C14 remained `blocked_pending_b6_review`, `activation_allowed=false`, `event_creation_allowed=false`, `projection_allowed=false`, with source hashes unchanged.
- No browser/runtime visual acceptance was claimed because 8911/5174 stayed stopped and reference-enabled runtime remains unauthorized.

## Delegated-Agent Output Review

Not applicable: Codex executed and reviewed the patch directly; no Hermes or delegated-agent output exists. The implementation is traceable to the Subject Timeline visual contract and senior medical-monitor perspective: default graph remains concise, but absence/partiality of date evidence is visible and source details remain available. No risk threshold or clinical inference was introduced.

## Residual Risk

- The browser/runtime experience still requires a separately authorized reference-enabled run after B6 reviewer outcomes, aggregate/CAS replay, and legacy source-token revalidation.
- Partial-date evidence is intentionally omitted from graph coordinates; the source detail row remains the next inspection surface, so reviewers must open the underlying source for date resolution.
- The existing Vite chunk-size warning remains; it is unrelated to this slice and was not expanded into a refactor.
